Spatial discovery of pyrotinib overcoming HER2-positive breast cancer resistance by breaking fibroblast-induced immune barriers
Drug Resistance Updates · 2025
DOI: 10.1016/j.drup.2025.101261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2025. Verfasst von Chenghui Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, PR China; Zhejiang Key Laboratory of Intellige…. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Acrylamides, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Province Natural Science Foundation, Medical Science and Technology Project of Zhejiang Province, Discipline Cluster of Oncology, Wenzhou Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, PR China; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospit…
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, PR China.
- Department of Pathology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, PR China.
- Department of Anesthesiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, PR China.
- Department of Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, PR China; Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Second Affiliated…
- Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, PR China.
Förderung
- Zhejiang Province Natural Science Foundation
- Medical Science and Technology Project of Zhejiang Province
- Discipline Cluster of Oncology, Wenzhou Medical University
- National Natural Science Foundation of China
- Wenzhou Medical University
Zitieren
APA
Yang, C., Xu, Y., Lin, Z., Zhang, A., Li, L., Ye, Z., Zhang, Q., Hu, H., Ren, G., Cheng, P., Wang, Z., & Wang, O. (2025). Spatial discovery of pyrotinib overcoming HER2-positive breast cancer resistance by breaking fibroblast-induced immune barriers. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2025.101261
Vancouver
Yang C, Xu Y, Lin Z, Zhang A, Li L, Ye Z, et al. Spatial discovery of pyrotinib overcoming HER2-positive breast cancer resistance by breaking fibroblast-induced immune barriers. Drug Resistance Updates. 2025. doi:10.1016/j.drup.2025.101261
BibTeX
@article{Yang2025,
author = {Yang, Chenghui and Xu, Yiying and Lin, Zhongmin and Zhang, Anqi and Li, Lili and Ye, Zhiqiang and Zhang, Qiongying and Hu, Hanwen and Ren, Guohong and Cheng, Pu and Wang, Zhen and Wang, Ouchen},
title = {Spatial discovery of pyrotinib overcoming HER2-positive breast cancer resistance by breaking fibroblast-induced immune barriers},
journal = {Drug Resistance Updates},
year = {2025},
doi = {10.1016/j.drup.2025.101261}
}
EUVIMED